Update on raloxifene: role in reducing the risk of invasive breast cancer in postmenopausal women
Victor G Vogel Cancer Institute, Geisinger Health System, Danville, PA, USA Abstract: Risk factors allow us to define women who are at increased lifetime risk for breast cancer, and the most important factor is age. Benign breast disease increases risk, and the most important histologies are atypica...
Guardado en:
Autor principal: | Vogel VG |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2011
|
Materias: | |
Acceso en línea: | https://doaj.org/article/3998cf20a4bf48b8a83fdb8b1d1e7361 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Gene expression in breast and adipose tissue after 12 months of weight loss and vitamin D supplementation in postmenopausal women
por: Caitlin Mason, et al.
Publicado: (2017) -
Invasive breast cancer in Argentine women: association between risk and prognostic factors with antigens of a peptidic and carbohydrate nature
por: Croce MV, et al.
Publicado: (2011) -
Tamoxifen for women at high risk of breast cancer
por: Nazarali SA, et al.
Publicado: (2014) -
Effect of reduced dietary fat on estradiol, adiponectin, and IGF-1 levels in postmenopausal women with breast cancer
por: Murillo-Ortiz B, et al.
Publicado: (2017) -
Role of the WASP and WAVE family proteins in breast cancer invasion and metastasis
por: Frugtniet B, et al.
Publicado: (2015)